Detalles de la búsqueda
1.
Multitargeting the Action of 5-HT6 Serotonin Receptor Ligands by Additional Modulation of Kinases in the Search for a New Therapy for Alzheimer's Disease: Can It Work from a Molecular Point of View?
Int J Mol Sci
; 23(15)2022 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35955902
2.
First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer's Disease.
J Med Chem
; 67(2): 1580-1610, 2024 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38190615
3.
Chalcogen-Varied Imidazolone Derivatives as Antibiotic Resistance Breakers in Staphylococcus aureus Strains.
Antibiotics (Basel)
; 12(11)2023 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37998820
4.
Hydrophobicity modulation via the substituents at positions 2 and 4 of 1,3,5-triazine to enhance therapeutic ability against Alzheimer's disease for potent serotonin 5-HT6R agents.
Eur J Med Chem
; 260: 115756, 2023 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37657272
5.
Synthesis, computational and experimental pharmacological studies for (thio)ether-triazine 5-HT6R ligands with noticeable action on AChE/BChE and chalcogen-dependent intrinsic activity in search for new class of drugs against Alzheimer's disease.
Eur J Med Chem
; 259: 115695, 2023 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37567058
Resultados
1 -
5
de 5
1
Próxima >
>>